Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "SUIT-003 O2 ce D061"

From Bioblast
Line 6: Line 6:
|SUIT number=D061_ce1;(ce2Omy);ce3U;ce4Rot;ce5DMSO;ce6DMSO;ce7Ama
|SUIT number=D061_ce1;(ce2Omy);ce3U;ce4Rot;ce5DMSO;ce6DMSO;ce7Ama
}}
}}
::: '''[[MitoPedia: SUIT]]''' - Coupling control protocol (CCP) with the carrier of the plasma membrane-permeable succinate (MitoKit-CII/Succinate-nv) and plasma membrane-permeable malonate (MitoKit-CII/Malonate-nv] in living cells (ce): DMSO.
::: '''[[MitoPedia: SUIT]]''' - Coupling control protocol (CCP) with the carrier of the plasma membrane-permeable succinate ([MitoKit-CII/Succinate-nv]) and plasma membrane-permeable malonate ([MitoKit-CII/Malonate-nv]) in living cells (ce): DMSO.
::: '''[[SUIT protocol pattern]]:''' ce1;(ce2Omy);ce3U;ce4DMSO;ce5DMSO;ce6Rot;ce7Ama
::: '''[[SUIT protocol pattern]]:''' ce1;(ce2Omy);ce3U;ce4DMSO;ce5DMSO;ce6Rot;ce7Ama


SUIT-003 O2 ce D061 protocol is the control of the [[SUIT-003 O2 ce D060]] adding the [[Carrier control titrations|carrier]] DMSO in [[ROX]] instead of the plasma membrane-permeable succinate ([[MitoKit-CII/Succinate-nv]])and plasma membrane-permeable malonate ([[MitoKit-CII/Malonate-nv]]). Moreover,the SUIT-003 O2 ce D061 protocol allows to evaluate the [[coupling control state |coupling control]] of living cells. Respiratory capacities are tested in a sequence of coupling states: [[ROUTINE]] and [[ET]]. Optionally, to study [[LEAK-respiration]], the [[phosphorylation system]] might be inhibited by [[oligomycin]]. The final concentration of [[oligomycin]] has to be carefully optimized for various cell types, to minimize the inhibitory effect on the [[Electron transfer-pathway|electron transfer system]] which would lead to an underestimation of [[ET-capacity]]. ย 
SUIT-003 O2 ce D061 protocol is the control of the [[SUIT-003 O2 ce D060]] adding the [[Carrier control titrations|carrier]] DMSO in [[ROX]] instead of the plasma membrane-permeable succinate ([[MitoKit-CII/Succinate-nv]]) and plasma membrane-permeable malonate ([[MitoKit-CII/Malonate-nv]). Moreover, the SUIT-003 O2 ce D061 protocol allows to evaluate the [[coupling control state |coupling control]] of living cells. Respiratory capacities are tested in a sequence of coupling states: [[ROUTINE]] and [[ET]]. Optionally, to study [[LEAK-respiration]], the [[phosphorylation system]] might be inhibited by [[oligomycin]]. The final concentration of [[oligomycin]] has to be carefully optimized for various cell types, to minimize the inhibitory effect on the [[Electron transfer-pathway|electron transfer system]] which would lead to an underestimation of [[ET-capacity]]. ย 




__TOC__
__TOC__
ย  Communicated byย  [[Garcia-Souza LF]] and [[Gnaiger E]](last update 2019-06-26)
ย  Communicated byย  [[Garcia-Souza LF]] and [[Gnaiger E]](last update 2019-06-27)


{{Template:SUIT-003 O2 ce D061}}
{{Template:SUIT-003 O2 ce D061}}


== Strengths and limitations ==
== Strengths and limitations ==
:::* [[CIV]] activity can also be measured after the cell viability test module.
:::* The [[SUIT-003 O2 ce D060]] is a cell [[coupling control protocol]]. The total cell count (''N''<sub>ce</sub>) is the sum of viable cells (''N''<sub>vce</sub>) and dead cells (''N''<sub>dce</sub>).
:::- The addition of [[oligomycin]] has to be carefully tested to avoid inhibitory effects in the evaluation of the [[ET-capacity]].
:::* This protocol can be extended with the cell viability test module (See CCV [[SUIT-003 O2 ce-pce D020]]).
:::* [[CIV]] activity can also be measured after the antimycin A titration or after the cell viability test module.
:::+ Reasonable duration of the experiment.
:::- To obtain [[LEAK]] respiration, the concentration of [[oligomycin]] has to be carefully tested to avoid inhibitory effects in the evaluation of the [[ET-capacity]].
:::- Careful washing is required after the experiment to avoid carry-over of inhibitors and uncoupler.





Revision as of 17:19, 27 June 2019


high-resolution terminology - matching measurements at high-resolution


SUIT-003 O2 ce D061

Description

Ce1;(ce2Omy);ce3U;ce4Rot;ce5DMSO;ce6DMSO;ce7Ama.png

Abbreviation: Carrier control of the plasma membrane-permeable succinate (MitoKit-CII/Succinate-nv) and plasma membrane-permeable malonate (MitoKit-CII/Malonate-nv) - SUIT-003 O2 ce D060

Reference: B

SUIT number: D061_ce1;(ce2Omy);ce3U;ce4Rot;ce5DMSO;ce6DMSO;ce7Ama

O2k-Application: O2

MitoPedia: SUIT - Coupling control protocol (CCP) with the carrier of the plasma membrane-permeable succinate ([MitoKit-CII/Succinate-nv]) and plasma membrane-permeable malonate ([MitoKit-CII/Malonate-nv]) in living cells (ce): DMSO.
SUIT protocol pattern: ce1;(ce2Omy);ce3U;ce4DMSO;ce5DMSO;ce6Rot;ce7Ama

SUIT-003 O2 ce D061 protocol is the control of the SUIT-003 O2 ce D060 adding the carrier DMSO in ROX instead of the plasma membrane-permeable succinate (MitoKit-CII/Succinate-nv) and plasma membrane-permeable malonate ([[MitoKit-CII/Malonate-nv]). Moreover, the SUIT-003 O2 ce D061 protocol allows to evaluate the coupling control of living cells. Respiratory capacities are tested in a sequence of coupling states: ROUTINE and ET. Optionally, to study LEAK-respiration, the phosphorylation system might be inhibited by oligomycin. The final concentration of oligomycin has to be carefully optimized for various cell types, to minimize the inhibitory effect on the electron transfer system which would lead to an underestimation of ET-capacity.


Communicated by  Garcia-Souza LF and Gnaiger E(last update 2019-06-27)
MitoPedia: SUIT

Steps and respiratory states

Ce1;(ce2Omy);ce3U;ce4Rot;ce5DMSO;ce6DMSO;ce7Ama.png

Step State Pathway Q-junction Comment - Events (E) and Marks (M)
ce1 ROUTINE ce1
  • ROUTINE respiration in the physiological coupling state R. Externally added permeable substrates could contribute to this respiratory state.


(ce2Omy) L(Omy) ce1;(ce2Omy)
  • Non-phosphorylating resting state (LEAK state); LEAK-respiration, L(Omy), after blocking the ATP synthase with oligomycin.
  • The addition of oligomycin is optional depending on the experimental question to resolve.
ce3U E cce1;(ce2Omy);ce3U
ce4Rot ROX ce1;(ce2Omy);ce3U;ce4Rot
  • Rox is the residual oxygen consumption in the ROX state, due to oxidative side reactions, estimated either after inhibition of CIII (e.g. antimycin A, myxothiazol), CIV (e.g. Cyanide) or in the absence of endogenous fuel-substrates. Rox is subtracted from oxygen flux as a baseline for all respiratory states, to obtain mitochondrial respiration.
ce5DMSO ROX ce1;(ce2Omy);ce3U;ce4Rot;ce5DMSO
  • Rox is the residual oxygen consumption in the ROX state, due to oxidative side reactions, estimated either after inhibition of CIII (e.g. antimycin A, myxothiazol), CIV (e.g. Cyanide) or in the absence of endogenous fuel-substrates. Rox is subtracted from oxygen flux as a baseline for all respiratory states, to obtain mitochondrial respiration.
ce6DMSO ROX ce1;(ce2Omy);ce3U;ce4Rot;ce5DMSO;ce6DMSO
  • Rox is the residual oxygen consumption in the ROX state, due to oxidative side reactions, estimated either after inhibition of CIII (e.g. antimycin A, myxothiazol), CIV (e.g. Cyanide) or in the absence of endogenous fuel-substrates. Rox is subtracted from oxygen flux as a baseline for all respiratory states, to obtain mitochondrial respiration.
ce7Ama ROX ce1;(ce2Omy);ce3U;ce4Rot;ce5DMSO;ce6DMSO;ce7Ama
  • Rox is the residual oxygen consumption in the ROX state, due to oxidative side reactions, estimated either after inhibition of CIII (e.g. antimycin A, myxothiazol), CIV (e.g. Cyanide) or in the absence of endogenous fuel-substrates. Rox is subtracted from oxygen flux as a baseline for all respiratory states, to obtain mitochondrial respiration.

Strengths and limitations

  • The SUIT-003 O2 ce D060 is a cell coupling control protocol. The total cell count (Nce) is the sum of viable cells (Nvce) and dead cells (Ndce).
  • This protocol can be extended with the cell viability test module (See CCV SUIT-003 O2 ce-pce D020).
  • CIV activity can also be measured after the antimycin A titration or after the cell viability test module.
+ Reasonable duration of the experiment.
- To obtain LEAK respiration, the concentration of oligomycin has to be carefully tested to avoid inhibitory effects in the evaluation of the ET-capacity.
- Careful washing is required after the experiment to avoid carry-over of inhibitors and uncoupler.


Compare SUIT protocols


References

MitoPedia concepts: SUIT protocol, SUIT B, Find 


MitoPedia methods: Respirometry